)
Edge23 Jan 2026
Death, Taxes, and Garbage: The Story of WM
How Waste Management turned garbage into one of America's most stable business models through landfills, regulation, and nationwide scale.
BioMarin Pharmaceutical
BioMarin Pharmaceutical (BMRN) investor relations material
BioMarin Pharmaceutical 44th Annual J.P. Morgan Healthcare Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.44th Annual J.P. Morgan Healthcare Conference summary12 Jan, 2026
Strategic transformation and growth
Achieved a 15% CAGR from FY'23 to FY'25, with preliminary FY'25 revenue at $3.2 billion and Voxzogo revenue at $920 million, driven by innovation and business unit focus.
Completed two M&A deals in 2025, including the $4.8 billion Amicus acquisition, to supplement internal innovation and diversify revenue.
Increased profitability by over 3x compared to topline growth in FY'24 and generated $728 million operating cash flow Q3'25 YTD.
Targeting sustained double-digit CAGR into the 2030s, leveraging new assets and pipeline advancements.
Cost transformation identified $500 million in savings, improving profitability and cash flow.
Pipeline and innovation highlights
Prioritized pipeline for transformative potential, with multiple data readouts and regulatory filings expected in the next 12 months.
Announced filing for full approval of Voxzogo in achondroplasia, with post-marketing requirements completed and two label expansions expected.
BMN 333 demonstrated over 13-fold increase in free CNP AUC; phase 2/3 study to initiate in 1H'26 for achondroplasia.
BMN 401 pivotal data in ENPP1 deficiency expected 1H'26, with potential to address 2,000–2,500 patients.
PALYNZIQ label expansion for adolescents (12–17 y/o) anticipated in 2026, with significant reduction in blood Phe and increased protein intake.
Amicus acquisition and integration
Amicus acquisition brings Galafold (Fabry disease) and Pombiliti/Opfolda (Pompe disease), expanding the enzyme therapy portfolio.
Galafold to be expanded from 40 to 80 countries, aiming to increase diagnosis, treatment, and patient reach.
Pombiliti available in 15 countries, with opportunities for label expansion and increased global access.
Pombiliti + Opfolda and Galafold, acquired via Amicus, represent $1 billion peak revenue opportunities each, with global expansion plans.
Confident in achieving accretive financial impact within 12 months post-closure and substantial accretion by 2027.
BMN 351: What functional data is key for market?
VOXZOGO IP: ITC decision impact and timeline?
Galafold: How to boost diagnosis/treatment rates?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next BioMarin Pharmaceutical earnings date
Q4 202518 Feb, 2026
BioMarin Pharmaceutical
Next BioMarin Pharmaceutical earnings date
Q4 202518 Feb, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
BioMarin Pharmaceutical Inc is a biotechnology company focused on developing and commercializing therapies for rare genetic diseases. Its research and product development efforts target conditions with limited treatment options, primarily in the fields of enzyme replacement and gene therapy. The company serves healthcare providers and patients worldwide through approved treatments and scientific initiatives. The company is headquartered in San Rafael, California, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage